Selected and favorite campaigns and concepts, including the US campaigns for cutquig, wilate and the global campaign for Eylea.  The US re-launch campaign for Brilinta, "Decisions Today Can Impact a Life," was a Med Ad News MANNY Awards finalist for Best Brand Team.  The Ovarian Cancer Awareness Video for Mt Sinai was a Med Ad News MANNY Awards finalist for Best Philanthropic Campaign. 

I have spent the bulk of my professional career writing and creating in the oncology and hematology arena.  From the strategy through execution, this work spans my entire career.  These brands include: 

Tafinlar and Mekinist for metastatic melanoma

TEVA Biosimilars Oncology Francise (Herzuma, Truxima)

Revlimid, an immunomodulatory agent fos multiple myeloma.

VITRAKVI, targed therapy for solid tumors (cancer) caused by NTRK genes

Arzerra, a monocolonal antibody for chronic lymphocytic leukemia

Bexxar, a radiolabeled monoclonal antibody for non-Hodgkin's lymphoma

Hycamtin for ovarian cancer and small cell lung cancer

Navelbine, for breast cancer

Argatroban, for heparin-induced thrombocytopenia

Cardiology brands have also occupied much of my professional career: anti-hypertensives, anti-platelets, and anti-coagulants.  I was the lead writer on the Plavix pitch, an account we continued as AOR for 9 years until the brand went generic.  This led to an opportunity to pitch a Plavix competitor, Brilinta, which I oversaw all Professional and Patient copy. In just a little over a years time, Brilinta grew to become the largest account in the history of McCann Health, along with a MANNY Award nomination for Best Brand Team.

The campaign for Intercept, an oral fluid drug test, was a finalist in the Medical Marketing & Media awards.